Australia markets open in 9 hours 51 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
421.96+11.73 (+2.86%)
As of 10:09AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 105.98B
Enterprise value 96.53B
Trailing P/E 26.63
Forward P/E 25.19
PEG ratio (5-yr expected) 0.55
Price/sales (ttm)10.50
Price/book (mrq)5.71
Enterprise value/revenue 9.48
Enterprise value/EBITDA 20.07

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 317.20%
S&P500 52-week change 325.38%
52-week high 3448.40
52-week low 3320.01
50-day moving average 3408.28
200-day moving average 3385.05

Share statistics

Avg vol (3-month) 31.04M
Avg vol (10-day) 31.11M
Shares outstanding 5258.3M
Implied shares outstanding 6258.46M
Float 8257.55M
% held by insiders 10.11%
% held by institutions 197.36%
Shares short (15 Apr 2024) 44.03M
Short ratio (15 Apr 2024) 44.2
Short % of float (15 Apr 2024) 41.56%
Short % of shares outstanding (15 Apr 2024) 41.56%
Shares short (prior month 15 Mar 2024) 44.13M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 324 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 39.46%
Operating margin (ttm)45.20%

Management effectiveness

Return on assets (ttm)12.81%
Return on equity (ttm)24.38%

Income statement

Revenue (ttm)10.18B
Revenue per share (ttm)39.49
Quarterly revenue growth (yoy)13.30%
Gross profit (ttm)N/A
EBITDA 4.57B
Net income avi to common (ttm)4.02B
Diluted EPS (ttm)15.43
Quarterly earnings growth (yoy)57.10%

Balance sheet

Total cash (mrq)10.17B
Total cash per share (mrq)39.38
Total debt (mrq)721.3M
Total debt/equity (mrq)3.89%
Current ratio (mrq)3.50
Book value per share (mrq)71.80

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A